| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 494,808 | 613,047 | 527,058 | 587,142 | | Cost of Revenue | 236,189 | 316,748 | 312,504 | 342,655 | | | Gross Profit | 258,619 | 296,299 | 214,554 | 244,487 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,576 | 140,630 | 27,595 | 30,773 | | Non Recurring | (4,701) | (39,460) | (21,447) | (1,507) | | Others | 40,499 | 38,613 | 36,230 | 33,461 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 198,245 | 156,516 | 172,176 | 181,760 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,745 | (21,223) | 12,781 | 2,098 | | Earnings Before Interest And Taxes | 199,990 | 135,293 | 184,957 | 183,858 | | Interest Expense | 379 | (13,153) | 13,624 |
-
| | Income Before Tax | 199,611 | 148,446 | 171,333 | 183,858 | | Income Tax Expense | 67,911 | 54,165 | 57,219 | 63,250 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 131,700 | 94,281 | 114,114 | 120,608 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 131,700 | 94,281 | 114,114 | 120,608 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $131,700 | $94,281 | $114,114 | $120,608 |
|
0.45% Nasdaq 
0.20%
Income Statement
